Table of Contents page: Clinical Colorectal Cancer

Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Select all

Download started.
Ok

Please select at least one article in order to proceed.

Colorectal Cancer: Epidemiology, Disease Mechanisms and Interventions to Reduce Onset and Mortality

Veronica Aran,
Ana Paula Victorino,
Luiz Claudio Thuler,
Carlos Gil Ferreira

Published online: February 12, 2016

p195-203

Colorectal Cancer in Patients With Inflammatory Bowel Disease: The Need for a Real Surveillance Program

Rosario Fornaro,
Michela Caratto,
Elisa Caratto,
...
Camilla Sticchi,
Marco Casaccia,
Enzo Andorno

Published online: February 12, 2016

p204-212

Oxaliplatin Immune-Induced Syndrome Occurs With Cumulative Administration and Rechallenge: Single Institution Series and Systematic Review Study

Katia Bencardino,
Gianluca Mauri,
Alessio Amatu,
...
Elisa Boiani,
Andrea Sartore-Bianchi,
Salvatore Siena

Published online: February 18, 2016

p213-221

A Phase II Efficacy and Safety, Open-Label, Multicenter Study of Imprime PGG Injection in Combination With Cetuximab in Patients With Stage IV KRAS-Mutant Colorectal Cancer

Neil H. Segal,
Purvi Gada,
Neil Senzer,
Michele A. Gargano,
Myra L. Patchen,
Leonard B. Saltz

Published online: February 13, 2016

p222-227

Autologous Cytokine-Induced Killer Cells Improves Overall Survival of Metastatic Colorectal Cancer Patients: Results From a Phase II Clinical Trial

Hua Zhao,
Yang Wang,
Jinpu Yu,
...
Nan Dong,
Hui Li,
Xiubao Ren

Published online: February 15, 2016

p228-235

Uracil-Tegafur and Oral Leucovorin Combined With Bevacizumab in Elderly Patients (Aged ≥ 75 Years) With Metastatic Colorectal Cancer: A Multicenter, Phase II Trial (Joint Study of Bevacizumab, Oral Leucovorin, and Uracil-Tegafur in Elderly Patients [J-BLUE] Study)

Tomohiro Nishina,
Toshikazu Moriwaki,
Mitsuo Shimada,
...
Hiroyasu Ishida,
Takashi Maeba,
Ichinosuke Hyodo

Published online: December 16, 2015

p236-242

PROSPECT Eligibility and Clinical Outcomes: Results From the Pan-Canadian Rectal Cancer Consortium

Dominick Bossé,
Jamison Mercer,
Soundouss Raissouni,
...
Anthony MacLean,
Winson Y. Cheung,
Michael M. Vickers

Published online: February 12, 2016

p243-249

Feasibility of Capecitabine and Oxaliplatin Combination Chemotherapy Without Central Venous Access Device in Patients With Stage III Colorectal Cancer

Alexandra Lapeyre-Prost,
Marine Hug de Larauze,
Benoist Chibaudel,
...
Julien Taieb,
Thierry André
on behalf of the Groupe Coopérateur Multidisciplinaire en Oncologie, the Fédération Francophone de la Cancérologie Digestive, and the UNICANCER Investigators of the PRODIGE Intergroup

Published online: November 29, 2015

p250-256

Concomitant Administration of Proton Pump Inhibitors and Capecitabine is Associated With Increased Recurrence Risk in Early Stage Colorectal Cancer Patients

Julia Sun,
Alastair I. Ilich,
Christina A. Kim,
...
Jennifer L. Spratlin,
Carole R. Chambers,
Michael B. Sawyer

Published online: December 27, 2015

p257-263

Analysis of Response-Related and Time-to-event Endpoints in Randomized Trials of Gemcitabine-Based Treatment Versus Gemcitabine Alone as First-Line Treatment of Patients With Advanced Pancreatic Cancer

Giuseppe Colloca,
Antonella Venturino,
Domenico Guarneri

Published online: November 28, 2015

p264-276

Screening for Colorectal Cancer Using a Multitarget Stool DNA Test: Modeling the Effect of the Intertest Interval on Clinical Effectiveness

Barry M. Berger,
Paul C. Schroy III,
Tuan A. Dinh

Published online: December 17, 2015

e65-e74

Open Access

Peptide Patterns as Discriminating Biomarkers in Plasma of Patients With Familial Adenomatous Polyposis

Lisa Agatea,
Sara Crotti,
Eugenio Ragazzi,
...
Salvatore Pucciarelli,
Donato Nitti,
Marco Agostini

Published online: December 18, 2015

e75-e92

Long-Term Health-Related Quality of Life in Patients With Rectal Cancer After Preoperative Short-Course and Long-Course (Chemo) Radiotherapy

Lisette M. Wiltink,
Remi A. Nout,
Jochem R.N. van der Voort van Zyp,
...
Andreas W.K.S. Marinelli,
Cornelis J.H. van de Velde,
Corrie A.M. Marijnen

Published online: February 12, 2016

e93-e99

Open Access

Therapeutic Evaluation of Biofeedback Therapy in the Treatment of Anterior Resection Syndrome After Sphincter-Saving Surgery for Rectal Cancer

Zhonglin Liang,
Wenjun Ding,
Wei Chen,
Zhongchuan Wang,
Peng Du,
Long Cui

Published online: November 27, 2015

e101-e107

Safety and Efficacy of Trifluridine/Tipiracil Monotherapy in Clinical Practice for Patients With Metastatic Colorectal Cancer: Experience at a Single Institution

Daisuke Kotani,
Kohei Shitara,
Akihito Kawazoe,
...
Toshihiko Doi,
Atsushi Ohtsu,
Takayuki Yoshino

Published online: November 27, 2015

e109-e115

Management of Epidermal Growth Factor Receptor Inhibitor-Induced Hypomagnesemia: A Systematic Review

Di (Maria) Jiang,
Kristopher Dennis,
Andrew Steinmetz,
...
Timothy R. Asmis,
Rachel A. Goodwin,
Michael M. Vickers

Published online: February 12, 2016

e117-e123

Primary Tumor Resection and Overall Survival in Patients With Metastatic Colorectal Cancer Treated With Palliative Intent

Shu Fen Wong,
Hui Li Wong,
Kathryn M. Field,
...
Ian Jones,
Matthew Croxford,
Peter Gibbs

Published online: December 29, 2015

e125-e132

Oxaliplatin-Induced Neuropathy: A Long-Term Clinical and Neurophysiologic Follow-Up Study

Panagiotis Kokotis,
Martin Schmelz,
Efthymios Kostouros,
Nikolaos Karandreas,
Meletios-Athanasios Dimopoulos

Published online: February 25, 2016

e133-e140

Editorial Board

Published in issue: September 2016

A2-A5

Publisher's Note

Clinical Skin Cancer: The Next Addition to Elsevier's Clinical Cancer (ECC) Journal Portfolio

Published in issue: September 2016

A12

September 2016

Reviews

Colorectal Cancer: Epidemiology, Disease Mechanisms and Interventions to Reduce Onset and Mortality

Colorectal Cancer in Patients With Inflammatory Bowel Disease: The Need for a Real Surveillance Program

Oxaliplatin Immune-Induced Syndrome Occurs With Cumulative Administration and Rechallenge: Single Institution Series and Systematic Review Study

Original Studies

A Phase II Efficacy and Safety, Open-Label, Multicenter Study of Imprime PGG Injection in Combination With Cetuximab in Patients With Stage IV KRAS-Mutant Colorectal Cancer

Autologous Cytokine-Induced Killer Cells Improves Overall Survival of Metastatic Colorectal Cancer Patients: Results From a Phase II Clinical Trial

Uracil-Tegafur and Oral Leucovorin Combined With Bevacizumab in Elderly Patients (Aged ≥ 75 Years) With Metastatic Colorectal Cancer: A Multicenter, Phase II Trial (Joint Study of Bevacizumab, Oral Leucovorin, and Uracil-Tegafur in Elderly Patients [J-BLUE] Study)

PROSPECT Eligibility and Clinical Outcomes: Results From the Pan-Canadian Rectal Cancer Consortium

Feasibility of Capecitabine and Oxaliplatin Combination Chemotherapy Without Central Venous Access Device in Patients With Stage III Colorectal Cancer

Concomitant Administration of Proton Pump Inhibitors and Capecitabine is Associated With Increased Recurrence Risk in Early Stage Colorectal Cancer Patients

Analysis of Response-Related and Time-to-event Endpoints in Randomized Trials of Gemcitabine-Based Treatment Versus Gemcitabine Alone as First-Line Treatment of Patients With Advanced Pancreatic Cancer

Available Exclusively Online at www.clinical-colorectal-cancer.com

Screening for Colorectal Cancer Using a Multitarget Stool DNA Test: Modeling the Effect of the Intertest Interval on Clinical Effectiveness

Peptide Patterns as Discriminating Biomarkers in Plasma of Patients With Familial Adenomatous Polyposis

Long-Term Health-Related Quality of Life in Patients With Rectal Cancer After Preoperative Short-Course and Long-Course (Chemo) Radiotherapy

Therapeutic Evaluation of Biofeedback Therapy in the Treatment of Anterior Resection Syndrome After Sphincter-Saving Surgery for Rectal Cancer

Safety and Efficacy of Trifluridine/Tipiracil Monotherapy in Clinical Practice for Patients With Metastatic Colorectal Cancer: Experience at a Single Institution

Management of Epidermal Growth Factor Receptor Inhibitor-Induced Hypomagnesemia: A Systematic Review

Primary Tumor Resection and Overall Survival in Patients With Metastatic Colorectal Cancer Treated With Palliative Intent

Oxaliplatin-Induced Neuropathy: A Long-Term Clinical and Neurophysiologic Follow-Up Study

Frontmatter

Editorial Board

Table of Contents

Publisher's Note

Clinical Skin Cancer: The Next Addition to Elsevier's Clinical Cancer (ECC) Journal Portfolio